Is Sendinblue (Brevo) HIPAA Compliant? BAA Policy and PHI Rules

Sendinblue's HIPAA Compliance Overview

Brevo (formerly Sendinblue) is an email and marketing automation platform. Whether you can use it in a HIPAA context depends on two pillars: an executed Business Associate Agreement and proven safeguards that protect Electronic Protected Health Information. Without a signed BAA and documented Privacy Safeguards aligned to the HIPAA Security Rule, you should not transmit or store PHI on the platform.

Think of HIPAA compliance as a shared model. The vendor must provide appropriate security and contractual commitments, while you configure the service, restrict data, and enforce internal Compliance Obligations. If either side falls short, the overall use will not be HIPAA compliant.

Business Associate Agreement Importance

A Business Associate Agreement is the legal prerequisite for sharing Protected Health Information with any cloud or email service that handles it on your behalf. The BAA allocates responsibilities, requires breach notification, and binds the vendor to HIPAA Security Rule standards.

• Scope: Defines what PHI/ePHI the vendor may process and for what purposes.
• Safeguards: Commits to administrative, physical, and technical controls, including Data Encryption and access management.
• Subprocessors: Requires oversight of any downstream service that may touch your data.
• Incident handling: Sets timelines for reporting and cooperating on potential exposures.

If a vendor will not sign a BAA for your account, you must treat the platform as out of scope for PHI—regardless of any security features it advertises.

Sendinblue's Security Measures

Security features are necessary but not sufficient for HIPAA use. When evaluating Brevo for regulated workflows, verify the presence and configuration of safeguards such as:

• Data Encryption in transit (TLS) and at rest, including key management practices.
• Strong authentication (MFA), role-based access controls, and least-privilege user roles.
• Comprehensive logging, audit trails, and retention controls suitable for ePHI.
• Message integrity protections (DKIM/DMARC) and secure handling of attachments and links.
• Documented incident response, vulnerability management, and regular security testing.

Even if all controls exist, HIPAA applicability still hinges on a signed BAA and your disciplined configuration and use.

Terms of Service Restrictions

Many marketing platforms limit or prohibit the transmission of sensitive data in their Terms of Service or Acceptable Use Policies. Review Brevo’s terms for explicit references to health data, sensitive identifiers, and regulated information. If the terms restrict PHI—or are silent while the vendor declines a BAA—you must assume PHI is not permitted.

Also confirm how the platform classifies campaigns (marketing vs. transactional). HIPAA marketing rules are stricter and often require patient authorization when PHI is involved.

Risks of Non-Compliance

Using a non-HIPAA-compliant email platform for PHI can trigger serious consequences: federal and state penalties, breach notifications, contractual disputes, and reputational harm. Operationally, you risk unauthorized disclosures via misaddressed messages, unsecured links, or long-lived contact databases containing ePHI.

Beyond fines, remediation is costly: forensics, patient outreach, monitoring services, and program overhauls. Preventing exposure with the right vendor and controls is far less expensive than responding after the fact.

Handling of Protected Health Information

Adopt a “no PHI by default” posture for marketing tools. Where possible, de-identify data or rely on consented communications that exclude diagnosis, treatment details, or other identifiers. Keep ePHI inside systems explicitly covered by BAAs and designed for clinical data.

• Do not place PHI in subject lines, preview text, URLs, or contact attributes.
• Use secured portals or forms for intake; share only minimal, non-identifying context by email.
• Segment lists to separate healthcare audiences from general marketing subscribers.
• Establish retention limits and purge workflows for contacts and message content.

Confirming Vendor HIPAA Practices

Before you consider any HIPAA-related use with Brevo, run a structured due diligence process:

• Ask for a Business Associate Agreement specific to your account and use case.
• Request security documentation (e.g., SOC 2 reports, encryption details, data location, and subprocessor lists).
• Validate configuration options: MFA, role-based access, audit logs, retention controls, and secure templating.
• Map data flows to ensure ePHI never passes through components that are out of scope.
• Pilot with test data only, then conduct a formal risk assessment before go-live.

Bottom line: You may only use Brevo with PHI if the company executes a BAA for your account and you implement HIPAA-aligned safeguards. Without both, treat the platform as not appropriate for PHI.

FAQs

Does Sendinblue offer a Business Associate Agreement?

Availability can depend on the vendor’s current policies and your specific plan. The definitive step is to request a Business Associate Agreement from Brevo’s legal or compliance team. If the vendor declines to sign a BAA, you must not use the service for PHI.

Can Sendinblue be used to store PHI?

Only if Brevo signs a BAA for your account and you configure the service to meet HIPAA Security Rule requirements. In the absence of a BAA and documented safeguards, do not store or transmit PHI or ePHI through the platform.

What are the risks of using non-HIPAA compliant email platforms?

You face potential regulatory penalties, mandatory breach notifications, reputational damage, and costly remediation. Operational risks include unauthorized disclosures, insecure message content, and insufficient logging or retention controls.

How to verify HIPAA compliance of a vendor?

Request and execute a BAA, obtain security attestations, confirm Data Encryption standards, review subprocessor lists, and test access controls and audit logging. Complete a risk assessment to validate that Privacy Safeguards and Compliance Obligations are satisfied for your specific workflow.